Wuestec restructures Samsung relationshipAs Wuestec Medical gears up for commercialization of its new low-cost digital x-ray system, the U.S. x-ray company has restructured its relationship with Korean partner Samsung. Wuestec has taken over
As Wuestec Medical gears up for commercialization of its new low-cost digital x-ray system, the U.S. x-ray company has restructured its relationship with Korean partner Samsung. Wuestec has taken over full control of Samsungs interest in DigiX, a Canadian digital development joint venture formed to develop a CCD-based digital x-ray system. Wuestec will operate the venture as an internal R&D arm.
The joint ventures work had paired Samsungs expertise in CCD technology with Wuestecs capabilities in developing conventional x-ray units. Wuestec had displayed the product of DigiXs work, DX-1480, at the 1998 RSNA meeting.
Wuestec made the decision to buy out Samsung to assume more control over its supply of digital x-ray components, according to COO Martin Porter. The company purchased Samsungs interest in DigiX using cash, notes payable, and an equity stake in privately held Wuestec. Wuestec declined to comment on the price or what percentage of the Mobile, AL-based firm Samsung now owns.
DX-1480 is priced at $197,500, a level significantly below the $350,000 to $400,000 price range cited for other digital radiography (DR) systems. Wuestec officials have positioned DX-1480 to compete head-on with standard analog x-ray systems.
The company has lined up 70 x-ray dealerships in the U.S. to handle DX-1480 and hopes to begin installations of the new system this month. The firms own sales staff will handle national accounts. Internationally, Wuestec has formed distributor relationships in Europe, Asia/Pacific, and the Middle East. The company has begun installing the first production unit of DX-1480 at its clinical site at the University of South Alabama, also in Mobile, AL.
MRI-Based AI Radiomics Model Offers 'Robust' Prediction of Perineural Invasion in Prostate Cancer
July 26th 2024A model that combines MRI-based deep learning radiomics and clinical factors demonstrated an 84.8 percent ROC AUC and a 92.6 percent precision-recall AUC for predicting perineural invasion in prostate cancer cases.
Breast MRI Study Examines Common Factors with False Negatives and False Positives
July 24th 2024The absence of ipsilateral breast hypervascularity is three times more likely to be associated with false-negative findings on breast MRI and non-mass enhancement lesions have a 4.5-fold likelihood of being linked to false-positive results, according to new research.
Can Polyenergetic Reconstruction Help Resolve Streak Artifacts in Photon Counting CT?
July 22nd 2024New research looking at photon-counting computed tomography (PCCT) demonstrated significantly reduced variation and tracheal air density attenuation with polyenergetic reconstruction in contrast to monoenergetic reconstruction on chest CT.